Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2017-06-12 18:51:20
Reporting Period:
Filing Date:
Accepted Time:
2017-06-12 18:51:20
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1175151 Cytosorbents Corp CTSO Surgical & Medical Instruments & Apparatus (3841) 980373793
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1647591 G. Michael Bator C/o Cytosorbents Corp.
7 Deer Park Dr., Suite K
Monmouth Junction NJ 08852
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-06-09 1,500 $4.12 70,500 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
  1. Includes (i) the following restricted stock units ("RSUs") that will be settled into common stock upon vesting upon a "Change In Control" of CytoSorbents Corporation, as defined in the CytoSorbents Corporation 2014 Long-Term Incentive Plan: (a) 6,000 RSUs granted on February 24, 2017 and (b) 60,000 RSUs granted on June 7, 2016 and (ii) 4,500 shares of common stock owned by the reporting person (including 1,500 shares of common stock purchased in the open market on June 9, 2017 and reported on this Form 4).